28 results
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
6 Dec 23
Other Events
7:13am
and Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of synovial sarcoma.
About Afami-cel
Afami-cel is an engineered T-cell receptor
8-K
EX-99.1
bb3p1
8 Nov 23
Adaptimmune Reports Third Quarter Financial Results and Business Update
7:37am
8-K
EX-99.1
m2gc9z
9 Aug 23
Adaptimmune Reports Second Quarter Financial Results and Business Update
7:42am
8-K
EX-99.1
3hznu2896z6 3s2ch1kl
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
8-K
EX-99.1
zkc q9v58z3p14pv
25 Feb 21
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
7:37am
8-K
EX-99.1
h9s3 b0ui
6 Aug 20
Adaptimmune Reports Q2 Financial Results and Business Update
7:37am